A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shock
- 15 January 1992
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 182 (1), 269-275
- https://doi.org/10.1016/s0006-291x(05)80140-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Nonspecific defence mechanism: the role of nitric oxideImmunology Today, 1991
- Pathophysiology and Treatment of Septic ShockJAMA, 1991
- Immunotherapy with Bacterial EndotoxinsAdvances in experimental medicine and biology, 1990
- Metabolic Fate of Endotoxin in RatAdvances in experimental medicine and biology, 1990
- Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.JCI Insight, 1989
- Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A.The Journal of Immunology, 1988
- One-signal requirement for interferon-gamma production by human large granular lymphocytes.The Journal of Immunology, 1987
- Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.The Journal of Immunology, 1985
- Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.JCI Insight, 1983
- Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsAnalytical Biochemistry, 1982